Cancer stem cells in neuroblastoma therapy resistance

Neuroblastoma (NB) is the most common cancer of infancy and accounts for nearly one tenth of pediatric cancer deaths. This mortality rate has been attributed to the > 50% frequency of relapse despite intensive, multimodal clinical therapy in patients with progressive NB. Given the disease’s heter...

Descripción completa

Detalles Bibliográficos
Autores principales: Aravindan, Natarajan, Jain, Drishti, Somasundaram, Dinesh Babu, Herman, Terence S., Aravindan, Sheeja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924637/
https://www.ncbi.nlm.nih.gov/pubmed/31867574
http://dx.doi.org/10.20517/cdr.2019.72

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924637/
https://www.ncbi.nlm.nih.gov/pubmed/31867574
http://dx.doi.org/10.20517/cdr.2019.72

Ejemplares similares